NUV-868

N/A

Report date: 2025/03/12 20:00:47

Base Information

Drug NameNUV-868

Drug Alias NameNUV-868

ClassificationBiologics

Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors

TargetsBromodomain and extra terminal domain protein

Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[8]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuvation Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[7]

ATC CodeN/A